Drugplain

DayQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION 650 mg/30mL

acetaminophen, phenylephrine hydrochloride, dextromethorphan hydrobromide, and guaifenesin · SOLUTION · The Procter & Gamble Manufacturing Company

No Recall HistoryCurrently in Shortage
Plain English

DayQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION is a solution containing acetaminophen, phenylephrine hydrochloride, dextromethorphan hydrobromide, and guaifenesin at 650 mg/30mL, taken oral. Manufactured by The Procter & Gamble Manufacturing Company.

Key Facts

Brand Name
DayQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION
Generic Name
acetaminophen, phenylephrine hydrochloride, dextromethorphan hydrobromide, and guaifenesin
NDC Code (Product)
69423-990
Manufacturer
The Procter & Gamble Manufacturing Company
Strength
650 mg/30mL
Dosage Form
SOLUTION
Route
ORAL
Marketing Status
Application #
M012
Drug Class
Expectorant [EPC]
Marketing Start
03/22/2021

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

anxiety1 reports
drug hypersensitivity1 reports
feeling of body temperature change1 reports
headache1 reports
heart rate increased1 reports
migraine1 reports
visual impairment1 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

Uses • temporarily relieves common cold/flu symptoms: nasal congestion • sinus congestion & pressure cough due to minor throat & bronchial irritation • minor aches & pains headache • fever • sore throat • reduces swelling of nasal passages temporarily restores freer breathing through the nose promotes nasal and/or sinus drainage helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive.

Dosage & Administration

Directions take only as directed only use the dose cup provided do not exceed 4 doses per 24 hrs adults & children 12 yrs & over 30 mL every 4 hrs children 4 to under 12 yrs ask a doctor children under 4 yrs do not use

Warnings

Warnings Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take • more than 4 doses in 24 hrs, which is the maximum daily amount for this product • taken with other drugs containing acetaminophen • 3 or more alcoholic drinks every day while using this product Allergy Alert: Acetaminophen may cause severe skin reactions. Symptoms may include: • skin reddening • blisters • rash If a skin reaction occurs, stop use and seek medical help right away Sore throat warning: If sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, nausea, or vomiting, consult a doctor promptly.

Frequently Asked Questions

What is DayQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION used for?

DayQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION contains acetaminophen, phenylephrine hydrochloride, dextromethorphan hydrobromide, and guaifenesin. It is a solution taken oral. Consult your doctor for specific uses.

Is DayQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION a controlled substance?

DayQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION is not classified as a controlled substance by the DEA.

What is the generic name for DayQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION?

The generic name for DayQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION is acetaminophen, phenylephrine hydrochloride, dextromethorphan hydrobromide, and guaifenesin. There are 1 other brand versions of acetaminophen, phenylephrine hydrochloride, dextromethorphan hydrobromide, and guaifenesin.

What is the NDC code for DayQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION 650 mg/30mL?

The NDC (National Drug Code) for DayQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION 650 mg/30mL is 69423-990, listed by The Procter & Gamble Manufacturing Company.

Product NDC

69423-990

Package NDC

69423-990-08

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)